Granules India Stock

Granules India PEG

The PEG Ratio (Price/Earnings-to-Growth) of Granules India (GRANULES.NS) as of Aug 17, 2026 is 4.05. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 5.01 — a change of -19.18% (lower).

PEG

4.05

YoY

-19.18%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Granules India is 2026 4.05 . PEG Ratio (Price/Earnings-to-Growth) of Granules India was 2025 5.01 . It decreases by -19.18% lower compared to the previous year.
Access this data via the Eulerpool API

Granules India Stock analysis

What does Granules India do? Granules India Ltd is a registered company in Hyderabad, India, specializing in the manufacturing of pharmaceutical active ingredients and formulations, product development, biotechnology research, and diagnostics. The company was established in 1984 and has become one of the leading suppliers of pharmaceutical active ingredients. The origins of Granules India Ltd began as a small company with only a few employees. In 1991, the company started production of Allantoin, a cosmetic active ingredient. Over the years, the company steadily grew and expanded its production capacities. In 1995, Granules India Ltd began manufacturing pharmaceutical active ingredients as part of its business. In the late 90s, the company expanded into other countries to distribute its products worldwide. Today, the main markets for Granules India Ltd are India, North America, Europe, and Asia. The company also has distribution offices in the USA, Europe, and Asia. Granules India Ltd has divided its business model into three main sectors: 1. Pharmaceutical Active Ingredients (APIs) - Granules India Ltd specializes in the manufacturing of pharmaceutical active ingredients used in drug production. The company produces a wide range of APIs, including Paracetamol, Ibuprofen, Metformin, and more. 2. Formulations - Granules India Ltd also produces various pharmaceutical formulations such as tablets, capsules, suspensions, and more. The company is able to develop and manufacture customized formulations according to customer requirements. 3. Biologics - In recent years, the company has also invested in biotechnology research, particularly in the development and manufacturing processes of biologics such as antibody drugs. The field of diagnostics is also covered. Granules India Ltd has established a strong position as a manufacturer of pharmaceutical active ingredients in recent years. The company supplies many of the major pharmaceutical companies worldwide. It has six production facilities in India that manufacture pharmaceutical active ingredients and formulations. The company also supplies to other manufacturers to support their production processes. In terms of products, Granules India Ltd offers a wide range of pharmaceutical active ingredients and formulations, all manufactured to the highest quality and in compliance with international standards. Some of the company's most well-known products are Paracetamol, Ibuprofen, Metformin, and Tramadol, used in pain management. The wide range of formulations includes tablets, capsules, suspensions, and more, used in various therapy areas such as cardiology, oncology, neurology, and infectious diseases. Overall, Granules India Ltd has achieved a leading position in the market for pharmaceutical active ingredients and formulations. The company has invested in research and development in recent years to expand its product range and provide customized solutions. Granules India Ltd remains committed to meeting the high standards in the pharmaceutical industry and developing innovative products to meet the needs of its customers. Granules India is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Granules India stock

PEG Ratio (Price/Earnings-to-Growth) of Granules India is 4.05 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Granules India changed from 5.01 to 4.05, representing a -19.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Granules India since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Granules India with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Granules India

All Key Metrics — Granules India